Aljaz Hojski, Brigitta Gahl, Michael Tamm, Didier Lardinois
{"title":"利用三维节段hrct重建估计术后肺功能:右上肺叶切除术的回顾性初步研究。","authors":"Aljaz Hojski, Brigitta Gahl, Michael Tamm, Didier Lardinois","doi":"10.3390/jpm15080364","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives:</b> Can three-dimensional (3D) reconstruction software that simulates postoperative lung volumes more effectively identify suitable candidates for anatomical lung resection compared to conventional methods, particularly in personalized surgical planning? <b>Patients/Methods:</b> This single-center pilot study included 20 patients (10 females; age 68 ± 10 years) who underwent segmental or lobar VATS resection of the right upper lobe for NSCLC. Three-dimensional simulations from preoperative HRCT scans were correlated with measured pulmonary function and compared with predictions from the \"5% per segment rule\" and the model proposed by Brunelli et al. <b>Results:</b> Patients (8/20) with increased postoperative FEV1 [2.40 (0.56) vs. 2.30 (0.55)] had a lower proportion of healthy tissue [76 (18)% vs. 89 (10)%, <i>p</i> = 0.045] in 3D simulations than those with decreased FEV1. Mean postoperative FEV1 was 2.3 (0.54); the Brunelli model predicted 1.8 (0.36) and the \"5% rule\" 2.2 (0.54). Both models underestimated postoperative function, though the \"5% rule\" was more accurate. <b>Conclusions:</b> This pilot study suggests that 3D-HRCT reconstruction has the potential to facilitate patient-tailored identification of individuals who may derive greater benefit from surgical intervention compared to conventional methods. Further research is needed to determine whether this technology can more accurately predict postoperative pulmonary function in patients with severe COPD. Utilizing 3D-segmental-HRCT-reconstruction software, the advantages of lung resection in the context of NSCLC can be assessed on an individualized patient basis.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 8","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12387836/pdf/","citationCount":"0","resultStr":"{\"title\":\"Estimating Postoperative Lung Function Using Three-Dimensional Segmental HRCT-Reconstruction: A Retrospective Pilot Study on Right Upper Lobe Resections.\",\"authors\":\"Aljaz Hojski, Brigitta Gahl, Michael Tamm, Didier Lardinois\",\"doi\":\"10.3390/jpm15080364\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background/Objectives:</b> Can three-dimensional (3D) reconstruction software that simulates postoperative lung volumes more effectively identify suitable candidates for anatomical lung resection compared to conventional methods, particularly in personalized surgical planning? <b>Patients/Methods:</b> This single-center pilot study included 20 patients (10 females; age 68 ± 10 years) who underwent segmental or lobar VATS resection of the right upper lobe for NSCLC. Three-dimensional simulations from preoperative HRCT scans were correlated with measured pulmonary function and compared with predictions from the \\\"5% per segment rule\\\" and the model proposed by Brunelli et al. <b>Results:</b> Patients (8/20) with increased postoperative FEV1 [2.40 (0.56) vs. 2.30 (0.55)] had a lower proportion of healthy tissue [76 (18)% vs. 89 (10)%, <i>p</i> = 0.045] in 3D simulations than those with decreased FEV1. Mean postoperative FEV1 was 2.3 (0.54); the Brunelli model predicted 1.8 (0.36) and the \\\"5% rule\\\" 2.2 (0.54). Both models underestimated postoperative function, though the \\\"5% rule\\\" was more accurate. <b>Conclusions:</b> This pilot study suggests that 3D-HRCT reconstruction has the potential to facilitate patient-tailored identification of individuals who may derive greater benefit from surgical intervention compared to conventional methods. Further research is needed to determine whether this technology can more accurately predict postoperative pulmonary function in patients with severe COPD. Utilizing 3D-segmental-HRCT-reconstruction software, the advantages of lung resection in the context of NSCLC can be assessed on an individualized patient basis.</p>\",\"PeriodicalId\":16722,\"journal\":{\"name\":\"Journal of Personalized Medicine\",\"volume\":\"15 8\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12387836/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Personalized Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jpm15080364\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15080364","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Estimating Postoperative Lung Function Using Three-Dimensional Segmental HRCT-Reconstruction: A Retrospective Pilot Study on Right Upper Lobe Resections.
Background/Objectives: Can three-dimensional (3D) reconstruction software that simulates postoperative lung volumes more effectively identify suitable candidates for anatomical lung resection compared to conventional methods, particularly in personalized surgical planning? Patients/Methods: This single-center pilot study included 20 patients (10 females; age 68 ± 10 years) who underwent segmental or lobar VATS resection of the right upper lobe for NSCLC. Three-dimensional simulations from preoperative HRCT scans were correlated with measured pulmonary function and compared with predictions from the "5% per segment rule" and the model proposed by Brunelli et al. Results: Patients (8/20) with increased postoperative FEV1 [2.40 (0.56) vs. 2.30 (0.55)] had a lower proportion of healthy tissue [76 (18)% vs. 89 (10)%, p = 0.045] in 3D simulations than those with decreased FEV1. Mean postoperative FEV1 was 2.3 (0.54); the Brunelli model predicted 1.8 (0.36) and the "5% rule" 2.2 (0.54). Both models underestimated postoperative function, though the "5% rule" was more accurate. Conclusions: This pilot study suggests that 3D-HRCT reconstruction has the potential to facilitate patient-tailored identification of individuals who may derive greater benefit from surgical intervention compared to conventional methods. Further research is needed to determine whether this technology can more accurately predict postoperative pulmonary function in patients with severe COPD. Utilizing 3D-segmental-HRCT-reconstruction software, the advantages of lung resection in the context of NSCLC can be assessed on an individualized patient basis.
期刊介绍:
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.